Mempin R, Tran H, Chen C, Gong H, Kim Ho K, Lu S
But one of the most common questions patients ask is: How much weight can you actually lose with GLP-1 treatment
Current evidence best supports the potential use of GLP-1 agonists in patients where suppression of reward-seeking behavior related to food and alcohol is desired
If 30% of patients prescribed Zepbound discontinue within 6 months due to injection burden, side effects, supply issues, or cost, their real-world weight loss is closer to zero than to 22.5%
In some cases, a mini facelift or a standalone neck lift may be enough to address your concerns
Studies indicate that individuals with a BMI over 30 kg/m have approximately two to three times higher risk of developing DVT or PE compared to those with normal weight